1 Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com.

Slides:



Advertisements
Similar presentations
BREAST CANCER IN IDAHO This PowerPoint presentation was created as a collaborative effort among the Cancer Data Registry of Idaho/ Idaho.
Advertisements

Sylvia Le April 29, Disparities in Health Care Disparities in health care have serious impact on the quality of health care. Identifying health.
Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
Yao 1 Neuroendocrine Tumors James C. Yao, MD Associate Professor Deputy Chairman, Gastrointestinal Medical Oncology University of Texas M. D. Anderson.
Breast Cancer Reimbursement Policy in Taiwan Mao-Ting Sheen Director Bureau of National Health Insurance Department of Health, Executive Yuan November.
4.6 Assessment of Evaluation and Treatment 2013 Analytic Lung Cancer.
Is low-dose Aspirin use associated with a reduced risk of colorectal cancer ? a QResearch primary care database analysis Prof Richard Logan, Dr Yana Vinogradova,
Breast Imaging Made Brief and Simple
Impact of Cancer Diagnosis and Chemotherapy on Mammography Use Xinhua Yu, M.B., Ph.D. A. Marshall McBean, M.D., M.Sc. Beth A. Virnig, Ph.D., M.P.H Division.
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,
The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.
1 Copyright 2005 Medical Risk Appraisal and Life Expectancy Program Illustration Illustrating a Basic Approach to Life Expectancy in Medically Impaired.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
Analysis of Chlamydia Re-testing Rates Massachusetts Family Planning Update.
BEING ALIVE AND WELL AT WIND RIVER >Being Alive = Avoiding Premature Death >Being Well = Not needing high medical expenditures Methods I H S RPMS database.
1 Key concepts, data, methods and results Index Trends in cancer survival by ethnic and socioeconomic group, New Zealand, Soeberg M, Blakely.
Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.
Assessing Minority Participation in Clinical Trials: Setting Attainable Goals The Minority and Women Clinical Trials Recruitment Program Department of.
The Relationship of Surgeon and Hospital Volume with Long-Term Survival For Women with Breast Cancer Patrick J. Roohan New York State Department of Health.
Measurement Measuring disease and death frequency FETP India.
Skull Base Chordoma and Chondrosarcoma: Changes in National Radiotherapy Patterns and Survival Outcomes Henry S. Park, MD, MPH; Kenneth B. Roberts, MD;
Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.
Lecture 17 (Oct 28,2004)1 Lecture 17: Prevention of bias in RCTs Statistical/analytic issues in RCTs –Measures of effect –Precision/hypothesis testing.
Otis W. Brawley M.D. Director, Georgia Cancer Center Associate Director, Winship Cancer Institute Professor of Hematology, Oncology, and Epidemiology Emory.
INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.
Temporal, Geographic and Demographic Trends of Early Onset Breast Cancer (EOBC) in Hampden County, MA Holly S. Mason MD FACS Jane Garb MS.
Measures of Association
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
SEER Provided Data Mohammad Afnan Baqai 12/3/2009.
Data Sources-Cancer Betsy A. Kohler, MPH, CTR Director, Cancer Epidemiology Services New Jersey Department of Health and Senior Services.
Adolescent and Young Adult Oncology Scientific Meeting 2013 Epidemiology Working Group.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
1 Lecture 6: Descriptive follow-up studies Natural history of disease and prognosis Survival analysis: Kaplan-Meier survival curves Cox proportional hazards.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of colorectal cancer: case report and literature review Alexandra.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.
Senior Statistician Per-Henrik Zahl, MA MD PhD
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
Peterson-Kaiser Health System Tracker What are recent trends in cancer spending and outcomes?
Measuring the Effect of Obesity on Earnings Xiaoshu Han Department of Economcs.
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
What Factors Predict Outcome At Relapse After Previous Esophagectomy And Adjuvant Therapy in High-Risk Esophageal Cancer? Edward Yu 1, Patricia Tai 5,
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Estimating Absolute Risk Reductions Associated with Interventions in Patients with Type 2 Diabetes Jim Mold, M.D., M.P.H. Brian Firestone, MS2.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
Cervical cancer among Asian subgroups in California, Janet Bates, MD MPH California Cancer Registry NAACCR Annual Meeting Denver, Colorado June.
Chapter 2. **The frequency distribution is a table which displays how many people fall into each category of a variable such as age, income level, or.
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
The Role of the HCC Cancer Registry in Facilitating Cancer Research Linda Cope, CTR HCC Registry Coordinator
What does the data tell us? Colorectal CANCER IN NEVADA
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
Underwriting Breast Cancer
Age and Racial/Ethnic Disparities in the Diagnosis of Breast Cancer in an Urban Population Joanne K. Fagan PhD, Denise Fyffe, PhD, Nadine Jenkins, CTR,
Prognostic significance of tumor subtypes in male breast cancer:
Prognosis of younger patients in non-small cell lung cancer
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome  WILLIAM M.
Measurements of Risk & Association …
It is estimated that more than 1
Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Shawn S. Groth, MD, MS, Natasha.
Primary Cardiac Sarcoma
Megan Eguchi, MPh Sana karam, md, phd
GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR
NAACCR/IACR Combined Annual Conference 2019
Trends in survival from metastatic lung cancer in California,
Nadia Howlader, PhD National Cancer Institute
Presentation transcript:

1 Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

2 Contents Slides VIGNETTE EXAMPLE Integrated Large Database Analyses of Survival, Mortality & Life Expectancy in 3 a 70 Year-Old Female with Breast Cancer Applying for Life Insurance & Annuity ANALYZE Breast Carcinoma: Survival, Mortality, Life Expectancy: 4 – 14 Cohort Entry-Period: , Ages 65-74, Local Stage, Grades 3&4 * (Index Code: IC 70-32) SURVIVAL Table 1 Annual & Cumulative: Observed, Expected, & Relative Survival 4 Chart 1 Graph of Observed, Expected, Relative Cumulative Survival 5 MORTALITY Table 2 Breast Carcinoma Relative & Absolute Mortality 6 Chart 2 Annual Observed & Expected Deaths 7 Table 3 Aggregate Average Annual Mortality & Survival 8 Chart 3 Mortality Ratio; Cumulative Survival; Excess Death Rate 9 DEBITS/CREDITS Chart 4 Underwriting Action for Life Insurance 10 LIFE EXPECTANCY Table 4 Observed Life Expectancy at Attained Age Table 5 Expected (Normal) Life Expectancy at Attained Age Table 6 Comparative Life Expectancy 13 Chart 5 Graph of Comparative Life Expectancy 13 CLIENT DEMOGRAPHIC AND CLINICAL PROFILE 14 COMMUNICATING WITH DR. MILANO 15 * National Cancer Institute:Surveillance, Epidemiology, End Results; (SEER*Stat )

3 Underwriting Vignette 70 year old women non-smoker with recent history of a 2 cm. breast cancer localized to the right breast and microscopically determined to be adenocarcinoma, grades 3 & 4*. The patient is currently undergoing treatment with surgery, radiation and chemotherapy. She is applying for a $5 million policy of Variable Universal Life Insurance and a large paid-up annuity policy There are no other risk factors or impairments *Grade 3 = poorly differentiated adenocarcinoma *Grade 4= undifferentiated (anaplastic) adenocarcinoma Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

4

5

6

7

8 TABLE 3 BREAST CARCINOMA , AGES 65-74, LOCAL, GRADES 3&4 Relative Mortality (MR) = 100d/d’ Absolute Mortality (EDR) = 1000*(q-q’) Relative Survival = 100P/P’ Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

9

10 Chart 4 DEBITS and/or ADDITIONAL EXTRAS BREAST CARCINOMA, AGES 65-74, LOCAL, GRADES 3&4* 8/14/02 National Nancer Institute: SEER Cancer Data ; SEER*Stat DurationMortalityExcessAdditional Start-EndRatio (%)DebitsDeath RateExtras t to t+ch t100d/d'MR-100EDR$M X years SUGGESTED UNDERWRITING ACTION FOR LIFE INSURANCE Postpone 2-years, then: $14M x 5-years * Poorly differentiated / undifferentiated breast carcinoma Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

11 Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

12 Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

13 TABLE 6. Comparative (Observed vs. Expected) Life Expectancy at Attained Age 70* Obs. LifeExpt. Life Age x Expectancy Conclusion On the basis of the foregoing analysis and attached life tables, I conclude with a reasonable degree of medical probability, that the life expectancy of a group of 70 year old white women with the same set of risk factors as those found in this client is years. This is a reduction of 11.9 % below the life expectancy of years in the U.S. Decennial Life Tables for a population matched by age, sex, and race * U.S. Decennial Tables for White Females CHART 5. Comparative Life Expectancy in a 70 Year Old Women with Breast Cancer Localized, Grades 3& Ages 70-years to 109-years Years life Expectancy Obs. Life Expectancy Expt. Life Expectancy Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

14 FORMAT FOR MORTALITY AND LIFE EXPECTANCY PROJECTIONS Date: 8/14/2002 Client name: Jane Doe Sex: Female Height: 5' 5'' DOB: 7/14/1932 Weight: 135 lbs Smoker Status: NS Current Age: 70 years Type of Insurance Applied For: Term Policy Number: Brief Clinical History to Include: Diagnosis & Age at Dx:Breast carcinoma, local stage, grades 3&4; Age 70 Disease Extent: (i.e. 1-vessel, 2-vessel etc CAD); Local, Regional or Distant Stage Cancer, etc. Disease Severity: (i.e. ejection fraction for CAD); Tumor Grade (Well, Mod., Poorly, Undifferentiated) Treatments and Outcomes: Medical, Surgical, Radiation etcCurrent Med/Surg/Rad Complications: Comorbidities: Mild osteoarthritis Current Risk Factors: None; recent exercise stress test normal and lab profile normal Current Health and ADL Status: Projected Extra Mortality: See mortality tables, excess death rates (EDRs), underwriting action. Estimated Life Expectancy: years Percent (%) Life-Expectancy Years Lost: 11.90% Medical Risk Appraisal & Life Expectancy Date: 8/14/2002 Anthony F. Milano, M.D., M.P.H. Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com

15 ANTHONY F. MILANO, MD, MA, MPH Milano Life Expectancy Services, Inc. Consultant Medical Risk Appraisal & Life Expectancy Phone: (508) P.O. Box 127 Fax: (508) Cummaquid, MA, Colonel, USAF, MC, FS, Retired Copyright 2005, Anthony Milano, M.D. LifeExpectancy America.Com